Insights into Nanomedicine for Head and Neck Cancer Diagnosis and Treatment
Open accessThe DOI matches its Crossref record; 167 of the 169 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Head and neck cancers rank sixth among the most common cancers today, and the survival rate has remained virtually unchanged over the past 25 years, due to late diagnosis and ineffective treatments. They have two main risk factors, tobacco and alcohol, and human papillomavirus infection is a secondary risk factor. These cancers affect areas of the body that are fundamental for the five senses. Therefore, it is necessary to treat them effectively and non-invasively as early as possible, in order to do not compromise vital functions, which is not always possible with conventional treatments (chemotherapy or radiotherapy). In this sense, nanomedicine plays a key role in the treatment and diagnosis of head and neck cancers. Nanomedicine involves using nanocarriers to deliver drugs to sites of action and reducing the necessary doses and possible side effects. The main purpose of this review is to give an overview of the applications of nanocarrier systems to the diagnosis and treatment of head and neck cancer. Herein, several types of delivery strategies, radiation enhancement, inside-out hyperthermia, and theragnostic approaches are addressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 4 Drug delivery systems’ strategies for anticancer therapy: passive targeting and active targeting. Adapted with permission from [76].](https://figures.cochat.ai/paper-figures/5de7a8b810484466979d8b5ee5511140/insights-into-nanomedicine-for-head-and-neck-cancer-diagnosis-and-treatment-figure-4.jpg)




![Figure 6 Alterations in tumor growth over 5 weeks of treatment in 6 distinct groups of rats to study ways to overcome tumor radioresistance by increasing absorbed radiation in clinically relevant energy dosages using cetuximab carried by gold nanoparticles. Reprinted with permission from [125].](https://figures.cochat.ai/paper-figures/1230d0fdc467476ba4518a6917c4fc40/insights-into-nanomedicine-for-head-and-neck-cancer-diagnosis-and-treatment-figure-6.jpg)
![Figure 7 Nanotechnology in local hyperthermia: The nanoparticles are accumulated inside the tumor and are capable of absorbing energy from various external heat sources, thereby potentiating the effects of hyperthermia. On the right, in comparison with the left, it is possible see the effect that the nanoparticles have on heat in the tumor site. Nanoparticles focus the energy from the external source on the tumor to induce localized thermal destruction while minimizing the adverse effects on collateral tissues. Abbreviations: NPTT: nano-photo-thermal therapy. NMH: nano-magnetic hyperthermia. NaRFA: nano-radio-frequency ablation. NUH: nano-ultrasound hyperthermia. Reprinted with permission from [141].](https://figures.cochat.ai/paper-figures/2e455e94f080409cbb3c8681602eeaf5/insights-into-nanomedicine-for-head-and-neck-cancer-diagnosis-and-treatment-figure-7.jpg)
![Figure 8 Platelet-facilitated photothermal tumor therapy (PLT-PTT): Platelets (PLTs) after isolation in the blood were mixed with gold nanorods (AuNRs), which after an electroporation process, were taken up by the PLTs. The resulting AuNR-loaded PLTs (PLT-AuNRs) reached the tumor cells using in vivo photothermal tumor therapy (PTT). Reprinted with permission from [102].](https://figures.cochat.ai/paper-figures/463057db844e4cd48758498fc5367b30/insights-into-nanomedicine-for-head-and-neck-cancer-diagnosis-and-treatment-figure-8.jpg)
![Figure 9 Quadrapeutic strategy in cancer treatment: Systemic administration of gold colloids conjugated with antibodies and liposomal drugs to form nanoclusters in cancer cells; local application of a laser pulse through an endoscope to selectively generate plasmonic nanobubbles (PNBs) in cancer cells; selective amplification of radiation by the nanocluster in cancer cells. Reprinted with permission from [161].](https://figures.cochat.ai/paper-figures/44bfb390343d489c80478a1e53bd49c6/insights-into-nanomedicine-for-head-and-neck-cancer-diagnosis-and-treatment-figure-9.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, these formulations, often designed for multifunctionality, allow for the simultaneous delivery of therapeutic agents, contrast agents, or even multiple radionuclides, showcasing remarkable flexibility and synergistic therapeutic potential [65].”
From Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation (2024) · cites this paper as [65]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · cited 4×
“Head and neck cancer (HNC) is a complex and heterogeneous disease that encompasses a large number of cancer cell locations and is considered a leading cause of cancer death worldwide [4,6].”
BackgroundInfluentialNanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873 · cited 1×
“We would also like to see governments backing their scaled-up production, which will also their approval beforehand [48,166].”
BackgroundLiposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839 · cited 1×
“However, it was Gregory Gregoriadis who established the concept of drug encapsulation in liposomes [112,113].”
BackgroundFactors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699 · cited 1×
“Concerning the pharmacokinetics, biodistribution, and residence times of nanocarriers in the body, it was found that their biopersistence is high and that sometimes problems arise in their clearance, making these aspects also reliant on the design and development of such systems [167,171].”
BackgroundTherapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,920 · cited 2×
“With certain materials/structures, this mechanism can avoid recognition by the P-glycoproteins [67,84].”
BackgroundBertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824 · cited 3×
“In this sense, to personalize the therapeutic approach to be taken with each user, it is essential to understand the biological mechanisms related to the distribution and retention of nanocarriers in tumors [48,71].”
BackgroundNanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1958-5 · Cited by 2,586 · cited 1×
“Additionally, it is important to know their interactions with organ and biomarker systems in vivo [168].”
BackgroundChithrani, B. D., & Chan, W. C. W. (2007) · Nano Letters · doi:10.1021/nl070363y · Cited by 2,286 · cited 1×
“On the other hand, Au nanoparticles internalized in cells are also not easily eliminated, although there is some evidence for size-dependent exocytosis [167,173,174].”
BackgroundArgiris, A., Karamouzis, M. V., Raben, D., & Ferris, R. L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60728-x · Cited by 2,224
Vokes, E. E., Weichselbaum, R. R., Lippman, S. M., & Hong, W. K. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280306 · Cited by 2,211
Herskovic, A., Martz, K., Al-Sarraf, M., Leichman, L., Brindle, J., Vaitkevicius, V., Cooper, J., Byhardt, R., Davis, L., & Emami, B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206113262403 · Cited by 2,108 · cited 1×
“This strategy is used for advanced tumors and is reported to be superior to surgery or radiotherapy alone by 6–8% in terms of 5 year survival [21,25,51].”
MethodReddy, L. H., Arias, J. L., Nicolas, J., & Couvreur, P. (2012) · Chemical Reviews · doi:10.1021/cr300068p · Cited by 2,010 · cited 1×
“The fact that they do not present permanent magnetism adds value, since it prevents their aggregation [154,155].”
BackgroundContinuous base identification for single-molecule nanopore DNA sequencing
Clarke, J., Wu, H.-C., Jayasinghe, L., Patel, A., Reid, S., & Bayley, H. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.12 · Cited by 1,810 · cited 1×
“Nanotechnology can be applied in numerous fields of medicine, such as imaging [61], drug delivery [62], DNA sequencing [63], and tissue engineering [64].”
BackgroundNanoparticles as drug delivery systems
Wilczewska, A. Z., Niemirowicz, K., Markiewicz, K. H., & Car, H. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70901-5 · Cited by 1,445 · cited 2×
“They have enormous potential as carriers of bioactive molecules because of their small size and unique physicochemical and biological properties, making them promising for biomedical applications [55,80,81].”
BackgroundELSAYED, I., HUANG, X., & ELSAYED, M. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.07.035 · Cited by 1,354 · cited 2×
“Au Nps anti-EGRF monoclonal antibody (host mouse) EGFR Oral squamous carcinoma cells (OSCC) Targeted drug delivery of anti-EGFR antibody and photothermal agent (laser irradiation) [103]”
BackgroundMagnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles
Laurent, S., Dutz, S., Häfeli, U. O., & Mahmoudi, M. (2011) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2011.04.003 · Cited by 1,326 · cited 1×
“The National Cancer Institute distinguishes three types of hyperthermia, considering the location of its application: local hyperthermia, which aims to increase the temperature in a small area; regional hyperthermia, which encompasses larger areas of the body, such as limbs or organs; and total body hyperthermia, gene…”
BackgroundHashibe, M., Brennan, P., Chuang, S.-C., Boccia, S., Castellsague, X., Chen, C., Curado, M. P., Dal Maso, L., Daudt, A. W., Fabianova, E., et al. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0347 · Cited by 1,256 · cited 1×
“Thus, the cooccurrence of smoking and alcohol consumption increases the chance of developing HNC, though smoking is considered to be a more major risk factor than alcohol for this type of cancer [29,31].”
BackgroundChua, M. L. K., Wee, J. T. S., Hui, E. P., & Chan, A. T. C. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00055-0 · Cited by 1,236
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., & Blumenthal, R. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,069 · cited 1×
“However, it was Gregory Gregoriadis who established the concept of drug encapsulation in liposomes [112,113].”
BackgroundWu, J. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080771 · Cited by 1,030 · cited 1×
“Thus, sometimes good results on solid tumors from animal models can result in disappointing effects when applied to humans, so it is important to take this effect into account when applying a candidate drug to humans [74,75].”
BackgroundMachiels, J.-P., René Leemans, C., Golusinski, W., Grau, C., Licitra, L., & Gregoire, V. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.07.011 · Cited by 916
Lammers, T., Aime, S., Hennink, W. E., Storm, G., & Kiessling, F. (2011) · Accounts of Chemical Research · doi:10.1021/ar200019c · Cited by 870 · cited 1×
“Theragnostic platforms, such as liposome, gold, and iron-based nanoparticles, among others, can provide passive and active targeting, trigger drug release, and perform other therapeutic functions, and at the same time are less invasive than conventional diagnostic systems [159,160].”
BackgroundGold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements
Her, S., Jaffray, D. A., & Allen, C. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.012 · Cited by 865 · cited 1×
“Its high Z (Z = 79), high capacity for X-ray absorption, versatility, and special physicochemical characteristics allow gold nanoparticles (Au nanoparticles) to have a wide range of practical applications in cancer therapy, namely, as novel radiosensitizers [52,125,127,128].”
BackgroundRole of Src expression and activation in human cancer
Irby, R. B., & Yeatman, T. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203912 · Cited by 857 · cited 1×
“It is overexpressed and hyperactivated in this type of cancer [116].”
BackgroundRadiation oncology in the era of precision medicine
Baumann, M., Krause, M., Overgaard, J., Debus, J., Bentzen, S. M., Daartz, J., Richter, C., Zips, D., & Bortfeld, T. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.18 · Cited by 812
Riley, R. S., & Day, E. S. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1449 · Cited by 801 · cited 3×
“This absorbed light is transformed into heat, which irreversibly damages the surrounding tissue by the process of necrosis that is induced by heat [27,144].”
BackgroundNanomedicine: Principles, Properties, and Regulatory Issues
Soares, S., Sousa, J., Pais, A., & Vitorino, C. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00360 · Cited by 790
Nanoparticles in drug delivery: Past, present and future
Couvreur, P. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.04.010 · Cited by 696 · cited 1×
“They have enormous potential as carriers of bioactive molecules because of their small size and unique physicochemical and biological properties, making them promising for biomedical applications [55,80,81].”
BackgroundMagnetic Nanoparticles: From Design and Synthesis to Real World Applications
Kudr, J., Haddad, Y., Richtera, L., Heger, Z., Cernak, M., Adam, V., & Zitka, O. (2017) · Nanomaterials · doi:10.3390/nano7090243 · Cited by 628
Polymeric nanoparticles: Promising platform for drug delivery
El-Say, K. M., & El-Sawy, H. S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.052 · Cited by 608
Magnetic nanoparticle-based therapeutic agents for thermo-chemotherapy treatment of cancer
Hervault, A., & Thanh, N. T. K. (2014) · Nanoscale · doi:10.1039/c4nr03482a · Cited by 585 · cited 3×
“variety of experiments using different types of magnetic materials, such as various types of nanoparticles [143,147], together with radiotherapy or chemotherapy [148,149], to check the effect of hyperthermia [150].”
BackgroundNanotechnology in hyperthermia cancer therapy: From fundamental principles to advanced applications
Beik, J., Abed, Z., Ghoreishi, F. S., Hosseini-Nami, S., Mehrzadi, S., Shakeri-Zadeh, A., & Kamrava, S. K. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.062 · Cited by 579 · cited 2×
“Undirected heating of the tissues can lead to serious damage [27,141].”
BackgroundPassive and Active Drug Targeting: Drug Delivery to Tumors as an Example
Torchilin, V. P. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00477-3_1 · Cited by 573 · cited 3×
“One of the most effective ways to improve the specificity of a nanocarrier is by increasing its affinity for the target by using a molecule with the ability to recognize and bind to the target tissue [77].”
BackgroundBonvalot, S., Rutkowski, P. L., Thariat, J., Carrère, S., Ducassou, A., Sunyach, M.-P., Agoston, P., Hong, A., Mervoyer, A., Rastrelli, M., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30326-2 · Cited by 536 · cited 1×
“When sensitized by radiotherapy, it promotes targeted destruction of cancer cells [136,137].”
BackgroundNanotechnology and its Applications in Medicine
Nikalje, A. P. (2015) · Medicinal Chemistry · doi:10.4172/2161-0444.1000247 · Cited by 512 · cited 4×
“These carriers can improve the properties of drugs and their pharmacokinetics, depending on the intended use [66,68].”
BackgroundInfluentialTargeted temperature sensitive magnetic liposomes for thermo-chemotherapy
Pradhan, P., Giri, J., Rieken, F., Koch, C., Mykhaylyk, O., Döblinger, M., Banerjee, R., Bahadur, D., & Plank, C. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.002 · Cited by 468 · cited 1×
“This reduction can be achieved by localized release of the drug in the target using controlled drug delivery systems [66,68,69].”
BackgroundHyperthermia: a Potent Enhancer of Radiotherapy
Horsman, M. R., & Overgaard, J. (2007) · Clinical Oncology · doi:10.1016/j.clon.2007.03.015 · Cited by 463 · cited 1×
“However, from the therapeutic point of view, its use alone as a curative method is not feasible, and it must be combined with chemotherapy and/or radiotherapy [140].”
BackgroundNanotechnological applications in medicine
Caruthers, S. D., Wickline, S. A., & Lanza, G. M. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.01.006 · Cited by 441 · cited 3×
“Nanomedicine offers not only improvements for existing techniques, but also the possibility of developing new techniques with superior efficacy, by manipulating drugs at the molecular level and altering their physicochemical properties, such as their solubility and permeability; or facilitating their sustained or cont…”
BackgroundObstacles and opportunities in a forward vision for cancer nanomedicine
de Lázaro, I., & Mooney, D. J. (2021) · Nature Materials · doi:10.1038/s41563-021-01047-7 · Cited by 439
Aghebati‐Maleki, A., Dolati, S., Ahmadi, M., Baghbanzhadeh, A., Asadi, M., Fotouhi, A., Yousefi, M., & Aghebati‐Maleki, L. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29126 · Cited by 417 · cited 2×
“They should reach hepatic and spleen macrophages [68,70].”
BackgroundMAGNETIC NANOPARTICLE HYPERTHERMIA IN CANCER TREATMENT
GIUSTINI, A. J., PETRYK, A. A., CASSIM, S. M., TATE, J. A., BAKER, I., & HOOPES, P. J. (2010) · Nano LIFE · doi:10.1142/s1793984410000067 · Cited by 390
Quality of life among cancer patients
Nayak, M., George, A., Vidyasagar, M., Mathew, S., Nayak, S., Nayak, B., Shashidhara, Y., & Kamath, A. (2017) · Indian Journal of Palliative Care · doi:10.4103/ijpc.ijpc_82_17 · Cited by 385 · cited 1×
“It has a great impact on the quality of life, not only for the patient but also for his family, particularly at a psychological and emotional level, and is often associated with financial hardship [2,3].”
BackgroundImproving radiotherapy in cancer treatment: Promises and challenges
Chen, H. H. W., & Kuo, M. T. (2017) · Oncotarget · doi:10.18632/oncotarget.18409 · Cited by 372 · cited 1×
“Due to these advances, the overall survival rates of cancer radiation therapy have improved in the last two decades from about 30% to 80% in HNC [123].”
BackgroundGold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma
Hainfeld, J. F., Dilmanian, F. A., Zhong, Z., Slatkin, D. N., Kalef-Ezra, J. A., & Smilowitz, H. M. (2010) · Physics in Medicine and Biology · doi:10.1088/0031-9155/55/11/004 · Cited by 370 · cited 1×
“However, in the long term (>200 days), 67% of the rats that received the nanoparticles survived, whereas of those that did not received it, only 25% survived [131].”
BackgroundNew frontiers in nanotechnology for cancer treatment
Alexis, F., Rhee, J.-W., Richie, J. P., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2008) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.03.017 · Cited by 347 · cited 1×
“They have enormous potential as carriers of bioactive molecules because of their small size and unique physicochemical and biological properties, making them promising for biomedical applications [55,80,81].”
BackgroundRose-bengal-conjugated gold nanorods for in vivo photodynamic and photothermal oral cancer therapies
Wang, B., Wang, J.-H., Liu, Q., Huang, H., Chen, M., Li, K., Li, C., Yu, X.-F., & Chu, P. K. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.066 · Cited by 311 · cited 3×
“(2013) employed RB-conjugated AuNRs in photodynamic and photothermal oral cancer therapies [104].”
BackgroundMethodInfluentialSmatti, M. K., Al-Sadeq, D. W., Ali, N. H., Pintus, G., Abou-Saleh, H., & Nasrallah, G. K. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00211 · Cited by 309
Magnetic nanoparticles: a novel platform for cancer theranostics
Singh, A., & Sahoo, S. K. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2013.10.005 · Cited by 289 · cited 1×
“These systems have intrinsic magnetic properties that allow them to be used as contrast agents in MRI alongside with hyperthermia, and their biocompatibility allows them to act as drug carriers in a targeted manner by using an external magnetic field centered on the lesion [151].”
BackgroundEpidemiology of head and neck cancers: an update
Aupérin, A. (2020) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000629 · Cited by 286 · cited 1×
“These associations exist because these work environments and occupations are more conducive to smoking and/or alcohol consumption [30].”
BackgroundLandon, C. D. (2011) · The Open Nanomedicine Journal · doi:10.2174/1875933501103010038 · Cited by 281 · cited 1×
“used magnetite particles to increase the temperature of several tissue samples when exposed to a magnetic field [146].”
MethodSize-dependent tissue kinetics of PEG-coated gold nanoparticles
Cho, W.-S., Cho, M., Jeong, J., Choi, M., Han, B. S., Shin, H.-S., Hong, J., Chung, B. H., Jeong, J., & Cho, M.-H. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.02.013 · Cited by 281 · cited 1×
“On the other hand, Au nanoparticles internalized in cells are also not easily eliminated, although there is some evidence for size-dependent exocytosis [167,173,174].”
BackgroundNanotechnology in Medical Imaging: Probe Design and Applications
Cormode, D. P., Skajaa, T., Fayad, Z. A., & Mulder, W. J. M. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.165506 · Cited by 275 · cited 1×
“Nanotechnology can be applied in numerous fields of medicine, such as imaging [61], drug delivery [62], DNA sequencing [63], and tissue engineering [64].”
BackgroundMagnetic fluid hyperthermia: Advances, challenges, and opportunity
Kozissnik, B., Bohorquez, A. C., Dobson, J., & Rinaldi, C. (2013) · International Journal of Hyperthermia · doi:10.3109/02656736.2013.837200 · Cited by 267 · cited 1×
“Magnetite (Fe3O4) and maghemite (γ-Fe2O3) are the materials most widely used in superparamagnetic nanoparticles for biomedical applications [152].”
BackgroundThe global cancer burden and human development: A review
Fidler, M. M., Bray, F., & Soerjomataram, I. (2018) · Scandinavian Journal of Public Health · doi:10.1177/1403494817715400 · Cited by 263
What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right
Sun, D., Zhou, S., & Gao, W. (2020) · ACS Nano · doi:10.1021/acsnano.9b09713 · Cited by 263
Horsman, M. R., & Siemann, D. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2848 · Cited by 246 · cited 1×
“The tumor microenvironment, which presents as hypoxic and acidic, represents a stressor, sensitizing cancer cells to external factors such as high temperatures [142].”
BackgroundAdvanced Functional Nanomaterials for Theranostics
Huang, H., & Lovell, J. F. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201603524 · Cited by 242 · cited 1×
“Theragnostic platforms, such as liposome, gold, and iron-based nanoparticles, among others, can provide passive and active targeting, trigger drug release, and perform other therapeutic functions, and at the same time are less invasive than conventional diagnostic systems [159,160].”
BackgroundButterworth, K. T., Coulter, J. A., Jain, S., Forker, J., McMahon, S. J., Schettino, G., Prise, K. M., Currell, F. J., & Hirst, D. G. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/29/295101 · Cited by 238
Gharat, S. A., Momin, M., & Bhavsar, C. (2016) · Critical Reviews™ in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2016016272 · Cited by 220
Dendrimer-based Macromolecular MRI Contrast Agents: Characteristics and Application
Kobayashi, H., & Brechbiel, M. W. (2003) · Molecular Imaging · doi:10.1162/15353500200303100 · Cited by 202 · cited 1×
“As a function of their size, keeping all other parameters equivalent, it was found that dendrimers with less of 10 nm dendrimers were eliminated via the renal route, whereas larger dendrimers were eliminated via the liver [167,172].”
BackgroundMagnetic Nanoparticles – A Review
T K, I., & P K, L. (2010) · International Journal of Pharmaceutical Sciences and Nanotechnology · doi:10.37285/ijpsn.2010.3.3.1 · Cited by 188
Platelet‐Facilitated Photothermal Therapy of Head and Neck Squamous Cell Carcinoma
Rao, L., Bu, L., Ma, L., Wang, W., Liu, H., Wan, D., Liu, J., Li, A., Guo, S., Zhang, L., et al. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201709457 · Cited by 184 · cited 27×
“The sustainability of the SiAuNS-loaded Ma was reduced to 35% or 12% of the control values with irradiance (5 min) producing heat flux density of 14 or 28 W/cm2, respectively; but no significant cytotoxicity was detected for non-loaded Ma under the same conditions of PPTT exposure.”
BackgroundMethodInfluentialPezzuto, F., Buonaguro, L., Caponigro, F., Ionna, F., Starita, N., Annunziata, C., Buonaguro, F. M., & Tornesello, M. L. (2015) · Oncology · doi:10.1159/000381717 · Cited by 175 · cited 3×
“Additionally, the augmented expression of p16 protein in HPV-related tumors has significantly better disease-specific survival when compared with non-virus-related tumors that do not exhibit increased p16 protein expression [29].”
BackgroundNanotechnology: a promising method for oral cancer detection and diagnosis
Chen, X., Zhang, X., Liu, Q., Zhang, J., & Zhou, G. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0378-6 · Cited by 170 · cited 1×
“Moreover, they can also function as optical contrast agents during image-guided surgery [16,17].”
BackgroundMagnetic Nanoparticle-Based Hyperthermia for Head & Neck Cancer in Mouse Models
Zhao, Q., Wang, L., Cheng, R., Mao, L., Arnold, R. D., Howerth, E. W., Chen, Z. G., & Platt, S. (2012) · Theranostics · doi:10.7150/thno.3854 · Cited by 165 · cited 7×
“Magnetic iron oxide Nps HNSCC cell line (Tu212) of mouse xenograft model MFH [107]”
BackgroundInfluentialHead and neck cancer: from anatomy to biology
Bose, P., Brockton, N. T., & Dort, J. C. (2013) · International Journal of Cancer · doi:10.1002/ijc.28112 · Cited by 160 · cited 1×
“These tumors can range from poorly to well differentiated, and in fact, about 90% of all HNC are squamous cell carcinomas and variants [23,28,38].”
BackgroundAttaluri, A., Kandala, S. K., Wabler, M., Zhou, H., Cornejo, C. M., Armour, M., Hedayati, M. A., Zhang, Y., DeWeese, T. L., Herman, Č., et al. (2015) · International Journal of Hyperthermia · doi:10.3109/02656736.2015.1005178 · Cited by 157 · cited 1×
“variety of experiments using different types of magnetic materials, such as various types of nanoparticles [143,147], together with radiotherapy or chemotherapy [148,149], to check the effect of hyperthermia [150].”
BackgroundGold nanoparticle hyperthermia reduces radiotherapy dose
Hainfeld, J. F., Lin, L., Slatkin, D. N., Avraham Dilmanian, F., Vadas, T. M., & Smilowitz, H. M. (2014) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.05.006 · Cited by 152 · cited 1×
“The radiosensitizing effect of Au nanoparticles is based on the concept that high-atomicnumber materials absorb low kilovoltage (kV) X-rays efficiently and deposit plenty of the beam energy in tumor cells, resulting in enhanced radiation dose deposition specifically to tumor cells [129,130].”
BackgroundCombining magnetic particle imaging and magnetic fluid hyperthermia in a theranostic platform
Hensley, D., Tay, Z. W., Dhavalikar, R., Zheng, B., Goodwill, P., Rinaldi, C., & Conolly, S. (2017) · Physics in Medicine and Biology · doi:10.1088/1361-6560/aa5601 · Cited by 147
Piao, L., Zhang, M., Datta, J., Xie, X., Su, T., Li, H., Teknos, T. N., & Pan, Q. (2012) · Molecular Therapy · doi:10.1038/mt.2012.67 · Cited by 146 · cited 2×
“Cationic lipid Nps pre-microRNA-107 MicroRNA-107 Xenograft model of HNSCC cell lines (SCC15, SCC25, and CAL27 cells) Targeted pre-miR-107 delivery [86]”
BackgroundNanomedicine: Past, present and future – A global perspective
Chang, E. H., Harford, J. B., Eaton, M. A. W., Boisseau, P., Dube, A., Hayeshi, R. K., Swai, H., & Lee, D. S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.136 · Cited by 143 · cited 1×
“Nanomedicine offers not only improvements for existing techniques, but also the possibility of developing new techniques with superior efficacy, by manipulating drugs at the molecular level and altering their physicochemical properties, such as their solubility and permeability; or facilitating their sustained or cont…”
BackgroundAnticancer Activity of Rutin and Its Combination with Ionic Liquids on Renal Cells
Caparica, R., Júlio, A. L. G., Araújo, M. E., Baby, A. R., Fonte, P., Costa, J. G., & de Almeida, T. S. (2020) · Biomolecules · doi:10.3390/biom10020233 · Cited by 134 · cited 1×
“For surface modifications, soft nanoparticles can be functionalized with a diverse variety of hydrophilic and amphiphilic molecules, such as fluorophores or agents that provide in vivo stability to otherwise poorly soluble molecules or more make them less recognizable to macrophages [17,82,83].”
BackgroundSelf-citationHyperthermia in Cancer Treatment: A Primer
Baronzio, G. F., & Hager, E. D. (2006) · Springer eBooks · doi:10.1007/978-0-387-33441-7 · Cited by 132 · cited 2×
“Hyperthermia (HT) is the exposure of a specific surface or the whole organism to temperatures above the physiological level (between 40 and 45 ◦C) [138].”
BackgroundNanotechnology for tissue engineering: Need, techniques and applications
Kingsley, D. J., Ranjan, S., Dasgupta, N., & Saha, P. (2013) · Journal of Pharmacy Research · doi:10.1016/j.jopr.2013.02.021 · Cited by 131 · cited 1×
“Nanotechnology can be applied in numerous fields of medicine, such as imaging [61], drug delivery [62], DNA sequencing [63], and tissue engineering [64].”
BackgroundChallenges and opportunities in the advancement of nanomedicines
Wei, A., Mehtala, J. G., & Patri, A. K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.10.007 · Cited by 127 · cited 3×
“As a function of their size, keeping all other parameters equivalent, it was found that dendrimers with less of 10 nm dendrimers were eliminated via the renal route, whereas larger dendrimers were eliminated via the liver [167,172].”
BackgroundOral management strategies for radiotherapy of head and neck cancer
Kawashita, Y., Soutome, S., Umeda, M., & Saito, T. (2020) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2020.02.001 · Cited by 123 · cited 3×
“This strategy is used for advanced tumors and is reported to be superior to surgery or radiotherapy alone by 6–8% in terms of 5 year survival [21,25,51].”
BackgroundMethodEndo, K., Ueno, T., Kondo, S., Wakisaka, N., Murono, S., Itō, M., Kataoka, K., Kato, Y., & Yoshizaki, T. (2012) · Cancer Science · doi:10.1111/cas.12079 · Cited by 119 · cited 2×
“Polymer micelles -Poly(ethylene glycol)-poly(glutamic acid) block copolymers (PEG-P[Gu]) Cisplatin Oral HNSCC cell lines (OSC-19, OSC-20, HSC-3 and HSC-4) Cisplatin delivery [94]”
BackgroundPopovtzer, A., Mizrachi, A., Motiei, M., Bragilovski, D., Lubimov, L., Levi, M., Hilly, O., Ben‐Aharon, I., & Popovtzer, R. (2016) · Nanoscale · doi:10.1039/c5nr07496g · Cited by 111 · cited 5×
“Its high Z (Z = 79), high capacity for X-ray absorption, versatility, and special physicochemical characteristics allow gold nanoparticles (Au nanoparticles) to have a wide range of practical applications in cancer therapy, namely, as novel radiosensitizers [52,125,127,128].”
BackgroundInfluentialNanoparticle-mediated Gene Silencing Confers Radioprotection to Salivary Glands In Vivo
Arany, S., Benoit, D. S. W., Dewhurst, S., & Ovitt, C. E. (2013) · Molecular Therapy · doi:10.1038/mt.2013.42 · Cited by 103 · cited 2×
“As previously mentioned, it has been demonstrated that the drug combination approach has produced better results in tumor management [95].”
BackgroundTargeted magnetic nanoparticle hyperthermia for the treatment of oral cancer
Legge, C. J., Colley, H. E., Lawson, M. A., & Rawlings, A. E. (2019) · Journal of Oral Pathology & Medicine · doi:10.1111/jop.12921 · Cited by 96 · cited 1×
“One of the benefits of magnetic nanoparticles is that they release heat as a result of loss of hysteresis, Neel relaxation, and Brownian relaxation when under the influence of an alternating magnetic field [156,157].”
BackgroundMuhanna, N., Jin, C. S., Huynh, E., Chan, H., Qiu, Y., Jiang, W., Cui, L., Burgess, L., Akens, M. K., Chen, J., et al. (2015) · Theranostics · doi:10.7150/thno.13451 · Cited by 94 · cited 2×
“The results show that porphysomes enabled imaging of head and neck carcinomas and the targeted ablation of these tumors [162].”
BackgroundThe use of Nanocarriers for Drug Delivery in Cancer Therapy David R. Khan
Khan, D. R. (2010) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000024 · Cited by 93 · cited 1×
“All these factors promote increased EPR by passive nanocarriers [72,73].”
BackgroundCisplatin‐conjugated gold nanoparticles as a theranostic agent for head and neck cancer
Davidi, E. S., Dreifuss, T., Motiei, M., Shai, E., Bragilovski, D., Lubimov, L., Kindler, M. J. J., Popovtzer, A., Don, J., & Popovtzer, R. (2018) · Head & Neck · doi:10.1002/hed.24935 · Cited by 91 · cited 2×
“nosis and image-guided therapy, making it a promising theragnostic agent [163].”
BackgroundGuidi, A., Codecà, C., & Ferrari, D. (2018) · Medical Oncology · doi:10.1007/s12032-018-1096-5 · Cited by 89 · cited 1×
“Currently, the main chemotherapy drugs used in the treatment of HNC are antimetabolites, platinum compounds, taxanes like fluorouracil (5-FU), methotrexate (MTX), cisplatin, carboplatin, docetaxel, and paclitaxel; and various therapeutic protocols can be used, depending on the evolution and stage of the disease [11,46…”
BackgroundNanotechnology in Head and Neck Cancer: The Race Is On
El‐Sayed, I. H. (2010) · Current Oncology Reports · doi:10.1007/s11912-010-0087-2 · Cited by 84 · cited 1×
“Additionally, by changing the morphology (size, composition, shape) of the nanoparticles, the wavelength of light with which the nanoparticle absorbs maximal energy (SPR peak) can be adjusted to visible or near-infrared (NIR) (650–900 nm), by which the penetration of tissues by light is maximal [145].”
BackgroundLocal hyperthermia in head and neck cancer: mechanism, application and advance
Gao, S., Zheng, M. H., Ren, X., Tang, Y., & Liang, X. (2016) · Oncotarget · doi:10.18632/oncotarget.10350 · Cited by 84 · cited 5×
“This absorbed light is transformed into heat, which irreversibly damages the surrounding tissue by the process of necrosis that is induced by heat [27,144].”
BackgroundInfluentialDAMASCELLI, B., Patelli, G., Lanocita, R., Tolla, G. D., Frigerio, L. F., Marchianò, A. V., Garbagnati, F., Spreafico, C., Tichà, V., Regna‐Gladin, C., et al. (2003) · American Journal of Roentgenology · doi:10.2214/ajr.181.1.1810253 · Cited by 83 · cited 1×
“Of the 23 treated patients, 18 had a tumor response, 3 showed stable disease, and only 2 showed disease progression, substantiating the effectiveness of this approach as induction therapy [119].”
ResultSu, Z., Liu, D., Chen, L., Zhang, J., Ru, L., Chen, Z., Gao, Z., & Wang, X. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s215087 · Cited by 82 · cited 7×
“MFH has been approved in Europe for the treatment of multiform glioblastoma in a methodology that requires direct delivery of the nanoparticles to the tumor tissue [158].”
BackgroundMethodInfluentialImage‐guided tumor surgery: The emerging role of nanotechnology
Wojtynek, N. E., & Mohs, A. M. (2020) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1624 · Cited by 81 · cited 8×
“unchanged, thereby limiting the possibility of optical performance [17].”
BackgroundInfluentialMiladi, I., Aloy, M., Armandy, E., Mowat, P., Kryza, D., Magné, N., Tillement, O., Lux, F., Billotey, C., Janier, M. F., et al. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.06.013 · Cited by 80 · cited 4×
“Miladi et al. (2015) demonstrated the radiosensitizing effect of gadolinium-based nanoparticles (GBNs in combination with conventional photon radiation in radioresistant HNSCC cell lines).”
BackgroundInfluentialMagnetic fluid hyperthermia of the mouse experimental tumor
Brusentsov, N. A., Nikitin, L. V., Brusentsova, T. N., Kuznetsov, A. A., Байбуртский, Ф. С., Shumakov, L. I., & Yurchenko, N. Y. (2002) · Journal of Magnetism and Magnetic Materials · doi:10.1016/s0304-8853(02)00634-0 · Cited by 79 · cited 1×
“variety of experiments using different types of magnetic materials, such as various types of nanoparticles [143,147], together with radiotherapy or chemotherapy [148,149], to check the effect of hyperthermia [150].”
BackgroundNanotheranostics: Advanced Nanomedicine for The Integration of Diagnosis and Therapy
Muthu, M. S., Mei, L., & Feng, S. (2014) · Nanomedicine · doi:10.2217/nnm.14.83 · Cited by 79
The role of recent nanotechnology in enhancing the efficacy of radiation therapy
Bergs, J. W. J., Wacker, M. G., Hehlgans, S., Piiper, A., Multhoff, G., Rödel, C. M., & Rödel, F. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.06.008 · Cited by 77 · cited 2×
“This effect also happens in other high-Z nanoparticles, being proportional to about Z4 [128].”
BackgroundNanotechnology Toward Treating Cancer
Pillai, G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814029-1.00009-0 · Cited by 76 · cited 16×
“They used liposomes and solid lipid nanoparticles (SLN) modified with a pH-sensitive, self-destructive PEG shell, and different peptides were designed as nanovectors for the delivery of irinotecan and miR-200 to enhance tumorspecific accumulation.”
BackgroundInfluential4D Multimodal Nanomedicines Made of Nonequilibrium Au–Fe Alloy Nanoparticles
Torresan, V., Forrer, D., Guadagnini, A., Badocco, D., Pastore, P., Casarin, M., Selloni, A., Coral, D. F., Ceolín, M. R., van Raap, M. B. F., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c03614 · Cited by 76 · cited 1×
“body reduces faster over the long term when compared to other gold or iron oxide contrast agents [177].”
BackgroundTrinidad, A. J., Hong, S. J., Peng, Q., Madsen, S. J., & Hirschberg, H. (2014) · Lasers in Surgery and Medicine · doi:10.1002/lsm.22235 · Cited by 74 · cited 12×
“Silica AuNanoshells HNSCC cells lines (Human FaDu cancer cell line—ATCC, HTB-43 and rat alveolar macrophages (NR8383; ATCC# CRL-2192) Plasmonic photothermal therapy (PPTT) and photodynamic therapy (PDT) [101]”
BackgroundInfluentialAstruc, D. (2015) · Molecules · doi:10.3390/molecules21010004 · Cited by 74
Basak, S. K., Zinabadi, A., Wu, A. W., Venkatesan, N., Duarte, V. M., Kang, J. J., Dalgard, C. L., Srivastava, M., Sarkar, F. H., Wang, M. B., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4181 · Cited by 70 · cited 4×
“Although curcumin sensitizes HNC cell lines to cisplatin [87], results have not been successful in some human clinical trials, due to poor absorption of curcumin by the gastrointestinal tract.”
BackgroundInfluentialLenouvel, D., González‐Moles, M. Á., Talbaoui, A., Ramos‐García, P., González‐Ruiz, L., Ruiz‐Ávila, I., & Montoya, J. A. G. (2019) · Oral Diseases · doi:10.1111/odi.13088 · Cited by 70 · cited 1×
“Its presence is thus associated with a negative prognosis [41,42].”
BackgroundHead and neck cancer: Proteomic advances and biomarker achievements
Rezende, T. M. B., Freire, M. D. S., & Franco, O. L. (2010) · Cancer · doi:10.1002/cncr.25245 · Cited by 69
Nanoparticle-Based Targeted Therapeutics in Head-And-Neck Cancer
Wu, T.-T., & Zhou, S.-H. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.10083 · Cited by 64 · cited 20×
“The controlled delivery of drugs has become increasingly important because of the advantages that this can bring to the pharmaceutical industry and cancer treatment: it allows a higher drug concentration to reach the tumor cells, while reducing the dose of the drug being administered [26,66].”
BackgroundInfluentialExpression of PD-1/PD-L1 in head and neck squamous cell carcinoma and its clinical significance
Chen, S.-W., Li, S.-M., Shi, D., Jiang, W.-M., Song, M., Yang, A., Li, Y.-D., Bei, J.-X., Chen, W.-K., & Zhang, Q. (2019) · International Journal of Biological Markers · doi:10.1177/1724600819884722 · Cited by 64 · cited 1×
“Its presence is thus associated with a negative prognosis [41,42].”
BackgroundStaal, A. H. J., Becker, K., Tagit, O., van Riessen, N. K., Koshkina, O., Veltien, A. A., Bouvain, P., Cortenbach, K. R. G., Scheenen, T. W. J., Flögel, U., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120307 · Cited by 64 · cited 1×
“Thus, the ultrastructure of the nanoparticle has a direct impact on the in vivo release of its contents [175].”
BackgroundMultiple cancers of the head and neck.
Ad, H. C., Danciu, C. E., & Popescu, C. R. (2013) · PubMed · Cited by 63
Nanobiotechnology-based Drug Delivery in Brain Targeting
Dinda, S., & Pattnaik, G. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666140608143719 · Cited by 60 · cited 1×
“These capabilities are very important in the case of HNC, because in some cases, to reach the therapeutic target it is necessary cross biological barriers such as the blood–brain barrier, which we know reduces drug delivery to the brain [15].”
BackgroundLang, L., Shay, C., Xiong, Y., Thakkar, P., Chemmalakuzhy, R., Wang, X., & Teng, Y. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0623-3 · Cited by 58 · cited 2×
“Comparatively, with free drug, the saracatinib-loaded polymeric nanoparticles revealed superior anticancer effects, avoiding metastasis more efficiently [110].”
BackgroundKurmi, B. D., Patel, P., Paliwal, R., & Paliwal, S. R. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101682 · Cited by 55 · cited 1×
“It involves a wide variety of nanostructures with small particle size distributions capable of crossing biological barriers and interacting with the target molecules of the therapy, among other structures present in the cells, reducing the effects of treatment on healthy cells [9,10].”
BackgroundYang, J., Ju, Z., & Dong, S. (2017) · Drug Delivery · doi:10.1080/10717544.2016.1236849 · Cited by 54 · cited 13×
“The results showed that PTX conveyed in this nanocarrier compared to free PTX had much higher antitumor activity, inducing apoptosis more effectively.”
BackgroundInfluentialIn vivo and in vitro effects of curcumin on head and neck carcinoma: a systematic review
Borges, G. Á., Rêgo, D. F., Assad, D. X., Coletta, R. D., Canto, G. D. L., & Guerra, E. N. S. (2016) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12455 · Cited by 53 · cited 1×
“Curcumin is a polyphenol derived from Curcuma longa and is extensively studied due to its potential as an anti-inflammatory, antibiotic, and antioxidant agent, and it also presents anticancer activity [114].”
BackgroundThe Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and Reality
Ferrari, D., Ghi, M. G., Franzese, C., Codecà, C., Gau, M., & Fayette, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00007 · Cited by 53 · cited 1×
“This strategy has been shown to reduce the progression of distant metastases, particularly in high-risk patients [49].”
BackgroundFonte, P., Andrade, F., Azevedo, C., Pinto, J. F., Seabra, V., van de Weert, M., Reis, S., & Sarmento, B. F. C. C. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2004-3 · Cited by 52 · cited 1×
“to provide anti-cancer drugs against HNC, namely, OSCC, are the biocompatible polymer poly (lactic-co-glycolic acid) (PLGA), which has the advantage of being degradable in an aqueous medium; the lactic and glycolic acid; and poly (ethylene glycol)-poly (glutamic acid), which is used as a block copolymer for the delive…”
BackgroundSelf-citationLo, Y.-L., Chang, C.-H., Wang, C.-S., Yang, M.-H., Lin, A. M.-Y., Hong, C.-J., & Tseng, W.-H. (2020) · Theranostics · doi:10.7150/thno.45164 · Cited by 52 · cited 2×
“Thus, this study has shown how combination therapy using pH-sensitive coatings and modified nanoparticle targeting can be a novel strategy for HNC treatment [91].”
BackgroundLi, H., Shi, L., Wei, J., Zhang, C., Zhou, Z., Wu, L., & Liu, W. X. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.07.053 · Cited by 50 · cited 4×
“The results showed that the intracellular accumulation of SalB was higher when HN13, HN30, and Leuk1 cells were in the presence of the SalB–PLC-NPs complex (nano-SalB) compared to cells administered free SalB.”
BackgroundInfluentialCrozier, E. E., & Sumer, B. D. (2010) · Medical Clinics of North America · doi:10.1016/j.mcna.2010.05.014 · Cited by 49 · cited 15×
“Since the affected areas in these types of cancers are adjacent to the respiratory and digestive systems, the same agents that promote the development of cancer cells in HNCs also affect other organs throughout the body, including the lungs.”
BackgroundInfluentialMR Imaging Safety Considerations of Gadolinium-Based Contrast Agents
McDonald, J. S., & McDonald, R. J. (2020) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2020.06.001 · Cited by 47 · cited 2×
“In humans it was found that accumulation in the nervous system and consequent nephrogenic systemic syndrome effects occurred in most patients who underwent periodic magnetic resonance imaging (MRI) with gadolinium contrast agents [134,135].”
BackgroundDunn, L. A., Fury, M. G., Xiao, H., Baxi, S. S., Sherman, E. J., Korte, S. H., Pfister, C., Haque, S. S., Katabi, N., Ho, A. L., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx346 · Cited by 46
The role of tumor DNA as a diagnostic tool for head and neck squamous cell carcinoma
Chan, J. Y. K., Gooi, Z., & Agrawal, N. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.07.008 · Cited by 46 · cited 5×
“EGFR is highly expressed in normal epithelial cells, so alterations in its pathways can promote a malignant transformation of HNC [32].”
BackgroundInfluentialMultidisciplinary Care of the Patient with Head and Neck Cancer
Saloura, V., Langerman, A. J., Rudra, S., Chin, R., & Cohen, E. E. W. (2013) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2012.12.001 · Cited by 43 · cited 1×
“One of the standard combinations used to treat recurrent/metastatic HNC non-expressing PD-L1 is cisplatin/5FU/cetuximab, which allows an increase in the speed of response to therapy, although toxicity may also be higher than the alternatives [47,48].”
BackgroundStudy on the efficiency of nanosized magnetite and mixed ferrites in magnetic hyperthermia
Saldívar-Ramírez, M. M. G., Sánchez-Torres, C. G., Cortés-Hernández, D. A., Escobedo‐Bocardo, J. C., Almanza-Robles, J. M., Larson, A., Reséndiz-Hernández, P. J., & Acuña-Gutiérrez, I. O. (2014) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-014-5187-3 · Cited by 42 · cited 1×
“One of the benefits of magnetic nanoparticles is that they release heat as a result of loss of hysteresis, Neel relaxation, and Brownian relaxation when under the influence of an alternating magnetic field [156,157].”
BackgroundAl-Thawadi, H., Gupta, I., Jabeen, A., Skenderi, F., Aboulkassim, T., Yasmeen, A., Malki, M. I., Batist, G., Vranić, S., & Moustafa, A. A. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01348-y · Cited by 42 · cited 1×
“showed that HPV and EBV oncoviruses are co-present in squamous cell carcinomas, especially when they occur in the oral cavity, which may promote their initiation and/or progression; however, the mechanisms of this relationship need to be better elucidated [36].”
BackgroundHaider, M. A., Elsherbeny, A., Jagal, J., Hubatová-Vacková, A., & Ahmed, I. S. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090828 · Cited by 42 · cited 1×
“On the other hand, Haider et al. (2020) showed how optimization of the design of paclitaxel-loaded PLGA (poly(lactic-co-glycolic acid) nanoparticles (PTX-PLGA-nanoparticles) to ultra-small sizes, of about 53 nm and with EE% higher than 90%, allowed a 10-fold increase in drug release in vitro…”
BackgroundLi, H., Qu, X., Qian, W., Song, Y., Wang, C., & Liu, W. (2020) · Oral Diseases · doi:10.1111/odi.13751 · Cited by 42 · cited 5×
“Moreover, the results also showed higher efficacy cell cycle arrest and apoptosis, which reveals that the use of SLNs as nanocarriers promotes therapeutic success [109].”
BackgroundInfluentialDong, L., Sun, L., Li, W., Jiang, Y., Zhan, Y., Yu, L., Chen, Y., & Hong, G. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202008591 · Cited by 42 · cited 1×
“Thus, this group proposed a multifunctional theranostic nanosystem based on degradable and excretable ultrasmall transition metal selenide nanodots with a general bovine serum albumin-templated strategy to be used in high performance computed tomography [176].”
MethodAndrade, F., Fonte, P., Costa, A., Cunha-Reis, C., Nunes, R., Almeida, A., Ferreira, D., Oliva, M., & Sarmento, B. F. C. C. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0045 · Cited by 40 · cited 1×
“For surface modifications, soft nanoparticles can be functionalized with a diverse variety of hydrophilic and amphiphilic molecules, such as fluorophores or agents that provide in vivo stability to otherwise poorly soluble molecules or more make them less recognizable to macrophages [17,82,83].”
BackgroundSelf-citationFury, M. G., Sherman, E. J., Ho, A. L., Katabi, N., Sima, C. S., Kelly, K. W., Nwankwo, O., Haque, S. S., & Pfister, D. G. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-1894-y · Cited by 39 · cited 1×
“Thus, several groups have been attempting to perform targeted therapy with paclitaxel [117,118].”
BackgroundTargeted Dendrimer Chemotherapy in an Animal Model for Head and Neck Squamous Cell Carcinoma
Ward, B. B., Dunham, T., Majoros, I. J., & Baker, J. R. (2011) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2010.12.041 · Cited by 39 · cited 2×
“It was found that targeted therapy was effective against high folate receptor expression cell lines and could be delivered in molar doses three times that of free drug, allowing increased efficacy when compared with free MTX and control [97].”
BackgroundFuture trends and emerging issues for nanodelivery systems in oral and oropharyngeal cancer
Irimie, A. I., Sonea, L., Jurj, A. M., Mehterov, N. H., Zimța, A., Budişan, L., Braicu, C., & Berindan‐Neagoe, I. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s133219 · Cited by 39 · cited 1×
“With certain materials/structures, this mechanism can avoid recognition by the P-glycoproteins [67,84].”
BackgroundVergauwen, E., Vanbinst, A.-M., Brussaard, C., Janssens, P., De Clerck, D., Van Lint, M., Houtman, A. C., Michel, O., Keymolen, K., Lefevere, B., et al. (2018) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-017-0084-7 · Cited by 36 · cited 2×
“In humans it was found that accumulation in the nervous system and consequent nephrogenic systemic syndrome effects occurred in most patients who underwent periodic magnetic resonance imaging (MRI) with gadolinium contrast agents [134,135].”
BackgroundMagnetic Fluid Hyperthermia of Rodent Tumors Using Manganese Perovskite Nanoparticles
Bubnovskaya, L., Belous, A., Solopan, S., Kovelskaya, A., Bovkun, L., Podoltsev, A., Kondtratenko, I., & Osinsky, S. (2014) · Journal of Nanoparticles · doi:10.1155/2014/278761 · Cited by 34 · cited 1×
“variety of experiments using different types of magnetic materials, such as various types of nanoparticles [143,147], together with radiotherapy or chemotherapy [148,149], to check the effect of hyperthermia [150].”
BackgroundLu, W., Li, H., Huo, B., Meng, Z., Xue, M., Qiu, L., Ma, S., Yan, Z., Piao, C., & Ma, X. (2016) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2016.05.027 · Cited by 34
Rodrigues, A. R. O., Almeida, B. G., Rodrigues, J. D. S., Queiroz, M. J. R. P., Calhelha, R. C., Ferreira, I. C. F. R., Pires, A. L., Pereira, A. M., Araújo, J. P., Coutinho, P. J. G., et al. (2017) · RSC Advances · doi:10.1039/c7ra00447h · Cited by 34 · cited 1×
“Nanotechnology can be applied in numerous fields of medicine, such as imaging [61], drug delivery [62], DNA sequencing [63], and tissue engineering [64].”
BackgroundVenugopal, I., Pernal, S. P., Duproz, A., Bentley, J., Engelhard, H. H., & Linninger, A. A. (2016) · Materials Research Express · doi:10.1088/2053-1591/3/9/095010 · Cited by 33 · cited 1×
“variety of experiments using different types of magnetic materials, such as various types of nanoparticles [143,147], together with radiotherapy or chemotherapy [148,149], to check the effect of hyperthermia [150].”
BackgroundZhang, Z., Zhuang, L., Lin, Y., Yan, M., Lv, J., Li, X., Lin, H. L., Zhu, P., Lin, Q., & Xu, Y. (2020) · PubMed Central · Cited by 32
Simonet, S., Rodriguez‐Lafrasse, C., Beal, D. M., Gerbaud, S., Malésys, C., Tillement, O., Lux, F., Fayyad‐Kazan, H., Rachidi, W., & Ardail, D. (2020) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2020.2871 · Cited by 31 · cited 2×
“In addition autophagy/autophagic cell death further exacerbated this combination of effects; however, this mechanism is not yet perfectly understood [100].”
BackgroundChen, F., Kuriakose, M. A., Zhou, M., DeLacure, M. D., & Dunn, R. L. (2003) · Head & Neck · doi:10.1002/hed.10241 · Cited by 30 · cited 2×
“B-17 severe combined immunodeficiency spontaneous mutant mouse Cisplatin delivery [93]”
BackgroundUntreated head and neck cancer: Natural history and associated factors
Zolkind, P., Lee, J. J., Jackson, R. S., Pipkorn, P. J., & Massa, S. T. (2020) · Head & Neck · doi:10.1002/hed.26460 · Cited by 30 · cited 3×
“This procedure is fundamental because the extent of the tumor influences the prognosis and treatment [22,33].”
BackgroundGadolinium-based nanoparticles as sensitizing agents to carbon ions in head and neck tumor cells
Wozny, A., Aloy, M., Alphonse, G., Magné, N., Janier, M. F., Tillement, O., Lux, F., Beuve, M., & Rodriguez‐Lafrasse, C. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.07.015 · Cited by 29 · cited 5×
“creased clinical outcomes of patients [99].”
BackgroundInfluentialRole of radiotherapy in the treatment of metastatic head and neck cancer
Ordóñez, R., Otero, A. P., Jerez, I., Medina, J. A., Lupiañez-Perez, Y., & Gómez‐Millán, J. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s181697 · Cited by 29 · cited 1×
“Radiation therapy is also important in the control and palliation of symptoms in patients with advanced/incurable HNC, allowing tumor reduction, prevention of ulceration and bleeding, and pain control [45].”
BackgroundChang, C., Chen, C., Lin, L., Chang, C.-H., Chen, L., Wang, H.-E., Lee, T., & Lee, Y. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0116-8 · Cited by 28
Effect of socioeconomic status on survival in patients with head and neck cancer
Weizman, B., Golan, N., & Ronen, O. (2021) · Head & Neck · doi:10.1002/hed.26788 · Cited by 28 · cited 2×
“It is even the leading cause of death in developed countries, and the second in developing countries [3,4].”
BackgroundLi, R., Gao, R., Wang, Y., Liu, Z., Xu, H., Duan, A., Zhang, F., & Ma, L. (2020) · Scientific Reports · doi:10.1038/s41598-020-68203-y · Cited by 27 · cited 2×
“Another application of SLNs as a vehicle of compounds with anticancer activity in HNC and precancerous cells was in the work performed by Li et al. (2020) for the delivery of andrographolide (ADG) in the human immortalized oral epithelial (HIOEC), precancerous leucoplakia (Leuk1), HN6, and HN30…”
BackgroundLin, L., Chang, C., Chang, C.-H., Wang, H.-E., Chiou, S., Liu, R.-S., Lee, T., & Lee, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.11666 · Cited by 25 · cited 3×
“These observations were associated with a significant loss of EMT markers in tumor cells [88].”
BackgroundInfluentialLeBrun, A., & Zhu, L. K. (2018) · Wiley eBooks · doi:10.1002/9781119127420.ch29 · Cited by 24 · cited 8×
“MFH has been approved in Europe for the treatment of multiform glioblastoma in a methodology that requires direct delivery of the nanoparticles to the tumor tissue [158].”
BackgroundInfluentialImmunotherapy in head and neck cancer: The great challenge of patient selection
Napolitano, M., Schipilliti, F. M., Trudu, L., & Bertolini, F. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.102829 · Cited by 24 · cited 2×
“with ICIs and to reduce severe systemic toxicity [53,54].”
BackgroundRiestra‐Ayora, J., Sánchez‐Rodríguez, C., Palao‐Suay, R., Yanes‐Diaz, J., Martín‐Hita, A., Aguilar, M. R., & Fernández, R. S. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1923863 · Cited by 24 · cited 1×
“Thus, the inclusion of α-TOS in the design of nanoparticles is a promising strategy for HNC therapy, since it potentiates the PTX effect [121].”
BackgroundTargeted nanoparticles for head and neck cancers: overview and perspectives
Zhao, Y., Chen, H., Chen, X., Hollett, G., Gu, Z., Wu, J., & Liu, X. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1469 · Cited by 23
Oral Assessment and Management of the Patient with Head and Neck Cancer
Sroussi, H., Jessri, M., & Epstein, J. B. (2018) · Oral and Maxillofacial Surgery Clinics of North America · doi:10.1016/j.coms.2018.06.006 · Cited by 23 · cited 1×
“This process facilitates the choice of the most appropriate treatment or combination (surgery, radiation therapy, and chemotherapy) while also minimizing possible sequels, such as significant acute and chronic damage to the oral cavity, which is not limited to the hard tissue (teeth and alveolar bone) and the oral muc…”
BackgroundEnhanced nanodrug delivery in tumors after near‐infrared photoimmunotherapy
Inagaki, F. F., Furusawa, A., Choyke, P. L., & Kobayashi, H. (2018) · Nanophotonics · doi:10.1515/nanoph-2019-0186 · Cited by 23 · cited 2×
“Thus, sometimes good results on solid tumors from animal models can result in disappointing effects when applied to humans, so it is important to take this effect into account when applying a candidate drug to humans [74,75].”
BackgroundClinical Care and Rehabilitation in Head and Neck Cancer
(2019) · Springer eBooks · doi:10.1007/978-3-030-04702-3 · Cited by 22
Systemic Targeting Systems-EPR Effect, Ligand Targeting Systems
Pawar, P. V., Domb, A. J., & Kumar, N. (2013) · Advances in delivery science and technology · doi:10.1007/978-1-4614-9434-8_3 · Cited by 20
Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck
Xu, Q., Fang, M., Zhu, J., Dong, H., Cao, J., Yan, L., Leonard, F., Oppel, F., Sudhoff, H. H., Kaufmann, A. M., et al. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.47068 · Cited by 19 · cited 4×
“with ICIs and to reduce severe systemic toxicity [53,54].”
BackgroundInfluentialde Lima, J. M., Bonan, P. R. F., Pérez, D. E. D. C., Hier, M., Alaoui‐Jamali, M. A., & da Silva, S. D. (2020) · Nanomaterials · doi:10.3390/nano10101938 · Cited by 17
Qaraghuli, M. M. A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.559596 · Cited by 17 · cited 5×
“The main checkpoint proteins found in cancer cells involved in this type of response in HNC are PD-L1 and CTLA-4 [50].”
BackgroundInfluentialBernier, J. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9464-6 · Cited by 16
Head and Neck Cancer: An Overview
Stepnick, D. W., & Gilpin, D. (2010) · Seminars in Plastic Surgery · doi:10.1055/s-0030-1255328 · Cited by 15 · cited 3×
“With this analysis, it is also possible to establish the stage of the disease, which can vary from 0 to IV, the latter being the stage with the worst prognosis [11,43].”
BackgroundMethodA theranostic platform for localized magnetic fluid hyperthermia and magnetic particle imaging
Hensley, D. W., Tay, Z. W., Dhavalikar, R., Goodwill, P. W., Zheng, B., Rinaldi, C., & Conolly, S. (2017) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2256350 · Cited by 15
Nörenberg, D., Schmidt, F., Schinke, K., Frenzel, T., Pietsch, H., Giese, A., Ertl-Wagner, B. B., & Levin, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231495 · Cited by 15 · cited 1×
“These signs thus reflect adverse effects on the central nervous system [133].”
BackgroundThe Lipids of Biological Membranes
Yèagle, P. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800047-2.00002-4 · Cited by 14 · cited 1×
“Amphipathic molecules having a polar group and only one hydrocarbon tail are more prone to forming micelles [77,111].”
BackgroundUse of a Novel Polymer in an Animal Model of Head and Neck Squamous Cell Carcinoma
Pellionisz, P. A., Lin, Y., Clair, J. M., Luo, J., Suwarnasarn, A., Schaue, D., Elashoff, D. A., Palma‐Diaz, F., Dubinett, S. M., Sharma, S. P., et al. (2017) · Otolaryngology · doi:10.1177/0194599817730304 · Cited by 10 · cited 3×
“engineered a novel biocompatible polymer loaded with CCL21 cisplatin [96].”
BackgroundInfluentialBernier, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-27601-4 · Cited by 10
Chemically enhanced radiotherapy: visions for the future.
Revannasiddaiah, S., & Susheela, S. P. (2016) · PubMed · doi:10.3978/j.issn.2305-5839.2015.11.06 · Cited by 9
Birkeland, A. C., Swiecicki, P. L., Brenner, J. C., & Shuman, A. G. (2016) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2016.1208050 · Cited by 9 · cited 2×
“However, these are invasive methods and are associated with several serious side effects that compromise the patients’ quality of life, such as severe toxicity, mucositis, dysphagia, xerostomia, radiation dermatitis, hematologic toxicity, neurotoxicity, and ototoxicity [6,8].”
BackgroundPrinciples and management of head and neck cancer
Lester, S., & Yang, W.-Y. (2012) · Surgery (Oxford) · doi:10.1016/j.mpsur.2012.09.002 · Cited by 8 · cited 10×
“addition, these structures also protect the airways [21,22].”
BackgroundMethodInfluentialOral Squamous Cell Carcinoma and the Cutting Edge of Nanotechnology
Bharadwaj, R., & Medhi, S. (2020) · doi:10.30699/mci.4.2.36 · Cited by 8
Lukianova‐Hleb, E. Y., & Lapotko, D. O. (2015) · Head & Neck · doi:10.1002/hed.24018 · Cited by 7 · cited 2×
“In HNC therapy, there are some multifunctional nanocarriers for theragnostic purposes, such as quadrapeutics, which can be applied in the detection and eradication of HNSCC [161].”
BackgroundTargeted inhibition of tumor growth and angiogenesis
van der Meel, R. (2013) · Utrecht University Repository (Utrecht University) · Cited by 5
Targeting Stem Cells in Head and Neck Cancer Using Superparamagnetic Iron Oxide Nanoparticles
Thompson, A., Thapa, R., Galoforo, S., Hang, X., Buelow, K. L., & Wilson, G. D. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.06.2098 · Cited by 5 · cited 7×
“MFH has been approved in Europe for the treatment of multiform glioblastoma in a methodology that requires direct delivery of the nanoparticles to the tumor tissue [158].”
BackgroundInfluential
Research works printed but not linked: 5
- Mooore, K.L., Dalley, A.F., and Agur, A.M.R. (2017). Moore Clinically Oriented Anatomy, Wolters Kluwer India Pvt Ltd.
- Caban, 2014, Nanosystems for drug delivery, OA Drug Des. Deliv., 2, 1
- Niemirowicz, 2012, Nanocarriers in modern drug delivery systems, Chemik, 66, 868
- Ruba, 2018, Radiosensitizers and radioprotectors for effective radiation therapy—A review, Asian J. Appl. Sci. Technol., 2, 77
- Butterworth, 2010, UKPMC Funders Group nm gold particles: Potential application for cancer therapy, Evaluation, 21, 295101
Cited by
Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation
Dhoundiyal, S., Srivastava, S., Kumar, S., Singh, G., Ashique, S., Pal, R., Mishra, N., & Taghizadeh-Hesary, F. (2024) · European Journal of Medical Research · doi:10.1186/s40001-023-01627-0 · Cited by 144
“Moreover, these formulations, often designed for multifunctionality, allow for the simultaneous delivery of therapeutic agents, contrast agents, or even multiple radionuclides, showcasing remarkable flexibility and synergistic therapeutic potential [65].”
BackgroundBharath, G., Sabri, M. A., Hai, A., BANAT, F. A., & Haija, M. A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030868 · Cited by 118
Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems
Viegas, C., Patrício, A. B., Prata, J., Fonseca, L., Macedo, A. S., Duarte, S. O. D., & Fonte, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092363 · Cited by 50
Self-citationQureshi, M., Viegas, C., Duarte, S. O. D., Girardi, M., Shehzad, A., & Fonte, P. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124340 · Cited by 24
Self-citationNanotheranostics-based Management of Head and Neck Cancer
Chavda, V. P., Balar, P. C., & Patel, S. B. (2023) · Nanotheranostics · doi:10.7150/ntno.81724 · Cited by 28
Metadata
- Authors
- Viegas, C., Pereira, D. S. M., & Fonte, P.
- Affiliations
- Centro de Ciências do Mar do Algarve (PT)
- University of Minho (PT)
- University of Lisbon (PT)
- Corresponding author
- Fonte, Pedro
- Venue
- Materials
- Publisher
- MDPI AG
- Published
- 2022-03-11
- Volume
- 15
- Issue
- 6
- Pages
- 2086
- ISSN
- 1996-1944 (ISSN-L)
- PMC
- PMC8951645
- OpenAlex
- W4221071836
- Cited by
- 21
- References
- 169
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 4 · 2023: 5 · 2022: 1
- FWCI
- 0.38
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Materials (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by)
- Funders
- Fundação para a Ciência e Tecnologia (UIDB/04326/2020, UIDB/04565/2020, UIDP/04565/2020, LA/P/0140/2020, 2020.08839.BD)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Keywords
- head and neck cancer, nanomedicine, nanocarriers, drug delivery, cancer diagnosis, radiation enhancement, theranostics, non-invasive treatment, human papillomavirus, tobacco and alcohol risk factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.